Abstract: The present invention relates to an in vitro method of diagnosing a neurological disease associated with at least one symptom selected from the group comprising non-motor symptoms, sleep-wake disorders, sensory disorders, neuropsychiatric disorders and cognitive difficulties, comprising measuring the amount of active c-Rel factor in a biological sample comprising endogenus c-Rel factor from a patient.
Type:
Application
Filed:
January 21, 2015
Publication date:
January 5, 2017
Applicants:
UNIVERSITY OF BRESCIA, FONDEZIONE OSPEDALE HOSPITAL IN VENICE